Search Results - "Polrot, Mélanie"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Successful Tumor Electrochemotherapy Using Sine Waves by Garcia-Sanchez, Tomas, Mercadal, Borja, Polrot, Melanie, Muscat, Adeline, Sarnago, Hector, Lucia, Oscar, Mir, Lluis M.

    “…Objective: The purpose of this work is to assess the ability of sine waves to perform electrochemotherapy (ECT) and to study the dependence of the frequency of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma by Mangelinck, Adèle, da Costa, Maria Eugénia Marques, Stefanovska, Bojana, Bawa, Olivia, Polrot, Mélanie, Gaspar, Nathalie, Fromigué, Olivia

    Published in Scientific reports (23-08-2019)
    “…Osteosarcoma is the most prevalent primary bone malignancy in children and young adults. Resistance to chemotherapy remains a key challenge for effective…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells by Peyvandi, Sanam, Buart, Stéphanie, Samah, Boubekeur, Vétizou, Marie, Zhang, Yanyan, Durrieu, Ludovic, Polrot, Mélanie, Chouaib, Salem, Benihoud, Karim, Louache, Fawzia, Karray, Saoussen

    Published in Cancer research (Chicago, Ill.) (15-10-2015)
    “…The Fas receptor ligand FasL regulates immune cell levels by inducing apoptosis of Fas receptor-positive cells. Here, we studied the impact of host FasL on…”
    Get full text
    Journal Article
  6. 6

    Towards a clinical application of freeze-dried squalene-based nanomedicines by Rouquette, Marie, Ser-Le Roux, Karine, Polrot, Mélanie, Bourgaux, Claudie, Michel, Jean-Philippe, Testard, Fabienne, Gobeaux, Frédéric, Lepetre-Mouelhi, Sinda

    Published in Journal of drug targeting (03-07-2019)
    “…Squalene-adenosine (SQAd) nanoparticles (NPs) were found to display promising pharmacological activity similar to many other nanomedicines, but their long-term…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Assessment of quantitative perfusion parameters by dynamic contrast-enhanced sonography using a deconvolution method: an in vitro and in vivo study by Gauthier, Marianne, Tabarout, Farid, Leguerney, Ingrid, Polrot, Mélanie, Pitre, Stéphanie, Peronneau, Pierre, Lassau, Nathalie

    Published in Journal of ultrasound in medicine (01-04-2012)
    “…The purpose of this study was to investigate the impact of the arterial input on perfusion parameters measured using dynamic contrast-enhanced sonography…”
    Get full text
    Journal Article
  9. 9

    Suppressor of cytokine signaling 1 modulates invasion and metastatic potential of colorectal cancer cells by David, Muriel, Naudin, Cécile, Letourneur, Martine, Polrot, Mélanie, Renoir, Jack-Michel, Lazar, Vladimir, Dessen, Philippe, Roche, Serge, Bertoglio, Jacques, Pierre, Josiane

    Published in Molecular oncology (01-07-2014)
    “…Suppressor of cytokine signaling (SOCS) 1 is an inducible negative regulator of cytokine signaling but its role in human cancer is not completely established…”
    Get full text
    Journal Article
  10. 10

    Cetuximab increases concentrations of irinotecan and of its active metabolite SN-38 in plasma and tumour of human colorectal carcinoma-bearing mice by Chu, Céline, Abbara, Chadi, Tandia, Mahamadou, Polrot, Mélanie, Gonin, Patrick, Farinotti, Robert, Bonhomme-Faivre, Laurence

    Published in Fundamental & clinical pharmacology (01-12-2014)
    “…In a previous study, we showed that cetuximab, a monoclonal antibody directed towards epidermal growth factor receptor, could inhibit P‐glycoprotein (P‐gp), an…”
    Get full text
    Journal Article
  11. 11

    Therapeutic efficiency of everolimus and lapatinib in xenograft model of human colorectal carcinoma with KRAS mutation by Chu, Céline, Noël-Hudson, Marie-Sophie, Boige, Valérie, Goéré, Diane, Marion, Sylvie, Polrot, Mélanie, Bigot, Ludovic, Gonin, Patrick, Farinotti, Robert, Bonhomme-Faivre, Laurence

    Published in Fundamental & clinical pharmacology (01-08-2013)
    “…KRAS mutation is a negative predictive prognostic factor during metastatic colorectal cancer treatment with antiepidermal growth factor receptor antibodies…”
    Get full text
    Journal Article
  12. 12

    Impact of the arterial input function on microvascularization parameter measurements using dynamic contrast-enhanced ultrasonography by Gauthier, Marianne, Pitre-Champagnat, Stéphanie, Tabarout, Farid, Leguerney, Ingrid, Polrot, Mélanie, Lassau, Nathalie

    Published in World journal of radiology (28-07-2012)
    “…AIM: To evaluate the sources of variation influencing the microvascularization parameters measured by dynamic contrast-enhanced ultrasonography (DCE-US)…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Towards a clinical application of freeze-dried squalene-based nanomedicines by Rouquette, Marie, Ser-Le Roux, Karine, Polrot, Mélanie, Bourgaux, Claudie, Michel, Jean-Philippe, Testard, Fabienne, Gobeaux, Frédéric, Lepetre-Mouelhi, Sinda

    Published in Journal of drug targeting (21-02-2019)
    “…Squalene-adenosine (SQAd) nanoparticles (NPs) were found to display promising pharmacological activity similar to many other nanomedicines, but their long-term…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Assessment of Quantitative Perfusion Parameters by Dynamic Contrast‐Enhanced Sonography Using a Deconvolution Method by Gauthier, Marianne, Tabarout, Farid, Leguerney, Ingrid, Polrot, Mélanie, Pitre, Stéphanie, Peronneau, Pierre, Lassau, Nathalie

    Published in Journal of ultrasound in medicine (01-04-2012)
    “…Objectives The purpose of this study was to investigate the impact of the arterial input on perfusion parameters measured using dynamic contrast‐enhanced…”
    Get full text
    Journal Article